Article
Evaluating the effects of circulating inflammatory proteins as drivers and therapeutic targets for severe COVID-19
22 Feb 2024
Abstract excerpt
Objective: The relationships between circulating inflammatory proteins and COVID-19 have been observed in previous cohorts. However, it is not unclear which circulating inflammatory proteins may boost the risk of or protect against COVID-19. Methods: We performed Mendelian randomization (MR) analysis using GWAS summary result of 91 circulating inflammation-related proteins (N = 14,824) to assess their causal...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
